Australia's most trusted
source of pharma news
Friday, 19 June 2026
Friday, 19 June 2026
Subscribe
Login
News Headlines
News Headlines
News
Will evolutionary drug be funded?
Posted 19 June 2026 AM
An "evolution in the management approach" of a chronic disease has been approved by the TGA, but subsequent PBS subsidisation has been described as "challenging".
Novartis' highly selective oral BTK inhibitor Rhapsido has landed on the ARTG, the first and currently only BTK inhibitor to be approved to treat chronic spontaneous urticaria (CSU) in adults who remain symptomatic despite H1 antihistamine treatment.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (26)
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Sales Manager / Territory Manager - Christchurch
- Business Development Manager – Health Tech - Melbourne
- Business Development Manager – Health Tech - Brisbane
- GP Representative - Geelong
- Business Development Manager, Health Tech - Sydney
- Territory Manager - Gold Coast
- Sales Director - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (7)
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
Regulatory, Pharmacovigilance & QA (4)
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Other (10)
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- QC Analyst - Microbiology - Melbourne
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
- Talent Acquisition Coordinator - Mascot
- Portfolio Manager ANZ - Melbourne
- Director of Operations, HealthTech - Melbourne
- Talent Acquisition Coordinator - Mascot
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.